secwatch.observer — SEC 8-K summary
======================================

Issuer:     ALLURION TECHNOLOGIES, INC. (ALUR)
CIK:        0001964979
Form:       8-K
Filed at:   2024-08-13T23:59:59+00:00
Accession:  0000950170-24-095765
Event type: earnings
Sentiment:  negative
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Allurion Q2 revenue $11.8M, sequential +25%; French regulator suspends Balloon sales; FY guidance lowered to $40-45M
--------------------------------------------------------------------------------

- Q2 2024 revenue $11.8M, up 25% sequentially from Q1 but down from $13M in Q2 2023.
- Operating loss improved to $9.3M from $13.3M in Q2 2023; record procedure volume >10,000 balloon placements for second straight quarter.
- ANSM (French regulator) suspended Allurion Balloon sales; company withdrawing from France pending remediation plan on advertising and patient follow-up.
- Full-year 2024 revenue guidance reduced to $40-45M from prior; procedure volume growth expected 10-15%.
- Cash $19.3M at June 30; completed public offering in July 2024 for ~$22M gross proceeds.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1964979/000095017024095765/0000950170-24-095765-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1964979/000095017024095765/alur-20240813.htm
  HTML page:      https://secwatch.observer/filing/0000950170-24-095765

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer